Differential expression of E-cadherin gene in human neuroepithelial tumors

Genetics and Molecular Research

Volumn 7, Issue 2, 2008, Pages 295-304

  Motta, F J N ^a,b   Valera, E T ^a   Lucio Eterovic, A K B ^a   Queiroz, R G P ^a   Neder, L ^a   Scrideli, C A ^a   Machado, H R ^a   Carlotti Junior, C G ^a   Marie, S K N ^a   Tone, L G ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

Author keywords

Cancer; CDH1 expression; Neuroepithelial tumors; Real time polymerase chain reaction

Indexed keywords

UVOMORULIN;

ADOLESCENT; ADULT; ARTICLE; ASTROCYTOMA; BENIGN TUMOR; CANCER SURVIVAL; CELL ADHESION; CHILD; CLINICAL FEATURE; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; NEUROEPITHELIOMA; OVERALL SURVIVAL; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION;

EID: 47949122097     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/vol7-2gmr424     Document Type: Article

References (39)

1. Asano K, Kubo O, Tajika Y, Takakura K, et al. (2000). Expression of cadherin and CSF dissemination in malignant astrocytic tumors. Neurosurg. Rev. 23: 39-44.
2. Becker KF, Rosivatz E, Blechschmidt K, Kremmer E, et al. (2007). Analysis of the E-cadherin repressor Snail in primary human cancers. Cells Tissues Organs 185: 204-212.
3. Behin A, Hoang-Xuan K, Carpentier AF and Delattre JY (2003). Primary brain tumours in adults. Lancet 361: 323-331.
4. Cavallaro U and Christofori G (2001). Cell adhesion in tumor invasion and metastasis: loss of the glue is not enough. Biochim. Biophys. Acta 1552: 39-45.
5. Chen HC, Chu RY, Hsu PN, Hsu PI, et al. (2003). Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas. Cancer Lett. 201: 97-106.
6. Frühwald MC, O'Dorisio MS, Dai Z, Tanner SM, et al. (2001). Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas - implications for tumor biology and potential clinical utility. Oncogene 20: 5033-5042.
7. Garinis GA, Menounos PG, Spanakis NE, Papadopoulos K, et al. (2002). Hypermethylation-associated transcriptional silencing of E-cadherin in primary sporadic colorectal carcinomas. J. Pathol. 198: 442-449.
8. Graziano F, Humar B and Guilford P (2003). The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice. Ann. Oncol. 14: 1705-1713.
9. Guarino M, Rubino B and Ballabio G (2007). The role of epithelial-mesenchymal transition in cancer pathology. Pathology 39: 305-318.
10. Hazan RB, Qiao R, Keren R, Badano I, et al. (2004). Cadherin switch in tumor progression. Ann. N. Y. Acad. Sci. 1014: 155-163.
11. Heimberger AB, McGary EC, Suki D, Ruiz M, et al. (2005). Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas. Clin. Cancer Res. 11: 267-272.
12. Hirohashi S (1998). Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am. J. Pathol. 153: 333-339.
13. Howng SL, Wu CH, Cheng TS, Sy WD, et al. (2002). Differential expression of Wnt genes, beta-catenin and E-cadherin in human brain tumors. Cancer Lett. 183: 95-101.
14. Khatua S, Peterson KM, Brown KM, Lawlor C, et al. (2003). Overexpression of the EGFR/FKBP12/HIF-2alpha pathway identified in childhood astrocytomas by angiogenesis gene profiling. Cancer Res. 63: 1865-1870.
15. Lombaerts M, van Wezel T, Philippo K, Dierssen JW, et al. (2006). E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines. Br. J. Cancer 94: 661-671.
16. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, et al. (2007). The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 114: 97-109.
17. Masterson J and O'Dea S (2007). Posttranslational truncation of E-cadherin and significance for tumour progression. Cells Tissues Organs 185: 175-179.
18. Mol AJ, Geldof AA, Meijer GA, van der Poel HG, et al. (2007). New experimental markers for early detection of high-risk prostate cancer: role of cell-cell adhesion and cell migration. J. Cancer Res. Clin. Oncol. 133: 687-695.
19. Munaut C, Noel A, Hougrand O, Foidart JM, et al. (2003). Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas. Int. J. Cancer 106: 848-855.
20. Perego C, Vanoni C, Massari S, Raimondi A, et al. (2002). Invasive behaviour of glioblastoma cell lines is associated with altered organisation of the cadherin-catenin adhesion system. J. Cell Sci. 115: 3331-3340.
21. Pingoud-Meier C, Lang D, Janss AJ, Rorke LB, et al. (2003). Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma. Clin. Cancer Res. 9: 6401-6409.
22. Pokutta S and Weis WI (2007). Structure and mechanism of cadherins and catenins in cell-cell contacts. Annu. Rev. Cell Dev. Biol. 23: 237-261.
23. Pötter R, Czech TH and Dieckmann I (1998). Tumors of the central nervous system. In: Cancer in Children: Clinical Management (Voute PA, Kalifa C and Barrett A, eds.). Oxford University Press, New York, 175-180.
24. Redies C (2000). Cadherins in the central nervous system. Prog. Neurobiol. 61: 611-648.
25. Russo C, Pellarin M, Tingby O, Bollen AW, et al. (1999). Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors. Cancer 86: 331-339.
26. Schwartz B, Melnikova VO, Tellez C, Mourad-Zeidan A, et al. (2007). Loss of AP-2alpha results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo. Oncogene 26: 4049-4058.
27. Schwechheimer K, Zhou L and Birchmeier W (1998). E-cadherin in human brain tumours: loss of immunoreactivity in malignant meningiomas. Virchows Arch. 432: 163-167.
28. Scrideli CA, Cazzaniga G, Fazio G, Pirola L, et al. (2003). Gene expression profile unravels significant differences between childhood and adult Ph+ acute lymphoblastic leukemia. Leukemia 17: 2234-2237.
29. Shapiro L, Love J and Colman DR (2007). Adhesion molecules in the nervous system: structural insights into function and diversity. Annu. Rev. Neurosci. 30: 451-474.
30. Strother DR, Pollack IF, Gisher PG, Hunter JV, et al. (2002). Tumors of the central nervous system. In: Principles and Practice of Pediatric Oncology (Pizzo PA and Poplack DG, eds.). Lippincott Williams and Wilkins, Philadelphia, 751-824.
31. Takeichi M (1991). Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251: 1451-1455.
32. Uhlmann K, Rohde K, Zeller C, Szymas J, et al. (2003). Distinct methylation profiles of glioma subtypes. Int. J. Cancer 106: 52-59.
33. Utsuki S, Sato Y, Oka H, Tsuchiya B, et al. (2002). Relationship between the expression of E-, N-cadherins and beta-catenin and tumor grade in astrocytomas. J. Neurooncol. 57: 187-192.
34. Utsuki S, Oka H, Sato Y, Tsutiya B, et al. (2004). E, N-cadherins and beta-catenin expression in medulloblastoma and atypical teratoid/rhabdoid tumor. Neurol. Med. Chir. 44: 402-406.
35. Van Aken E, De Wever O, Correia da Rocha AS and Mareel M (2001). Defective E-cadherin/catenin complexes in human cancer. Virchows Arch. 439: 725-751.
36. Wijnhoven BP, Dinjens WN and Pignatelli M (2000). E-cadherin-catenin cell-cell adhesion complex and human cancer. Br. J. Surg. 87: 992-1005.
37. Yagi T and Takeichi M (2000). Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. Genes Dev. 14: 1169-1180.
38. Yi Kim D, Kyoon JJ, Kyu PY, Yeob RS, et al. (2007). E-cadherin expression in early gastric carcinoma and correlation with lymph node metastasis. J. Surg. Oncol. 96: 429-435.
39. Yu J, Zhang H, Gu J, Lin S, et al. (2004). Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma. BMC Cancer 4: 65.